BRKR
Bruker Corporation
NASDAQ: BRKR · HEALTHCARE · MEDICAL DEVICES
$36.71
+7.06% today
Updated 2026-04-30
Market cap
$5.52B
P/E ratio
—
P/S ratio
1.61x
EPS (TTM)
$-0.15
Dividend yield
0.55%
52W range
$28 – $56
Volume
2.0M
Bruker Corporation (BRKR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-0.25%
Operating margin
6.58%
ROE
-0.38%
ROA
2.90%
Debt/equity
0.76x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $435.83M | $18.48M | 45.74% | 7.04% | 4.24% |
| 2007 | $547.58M | $31.53M | 46.23% | 9.13% | 5.76% |
| 2008 | $1.11B | $64.90M | 45.61% | 9.77% | 5.86% |
| 2009 | $1.11B | $81.20M | 46.53% | 12.27% | 7.29% |
| 2010 | $1.30B | $95.40M | 46.44% | 11.93% | 7.31% |
| 2011 | $1.65B | $92.30M | 45.56% | 9.42% | 5.59% |
| 2012 | $1.79B | $77.50M | 46.41% | 8.71% | 4.33% |
| 2013 | $1.84B | $80.10M | 43.78% | 8.06% | 4.35% |
| 2014 | $1.81B | $56.70M | 42.20% | 5.83% | 3.13% |
| 2015 | $1.62B | $101.60M | 43.64% | 8.97% | 6.26% |
| 2016 | $1.61B | $153.60M | 46.08% | 11.00% | 9.53% |
| 2017 | $1.77B | $78.60M | 46.04% | 12.16% | 4.45% |
| 2018 | $1.90B | $179.70M | 47.48% | 13.84% | 9.48% |
| 2019 | $2.07B | $197.20M | 48.02% | 14.52% | 9.51% |
| 2020 | $1.99B | $157.80M | 47.29% | 12.49% | 7.94% |
| 2021 | $2.42B | $277.10M | 50.03% | 17.09% | 11.46% |
| 2022 | $2.53B | $296.60M | 51.59% | 17.10% | 11.72% |
| 2023 | $2.96B | $427.20M | 51.05% | 14.74% | 14.41% |
| 2024 | $3.37B | $113.10M | 49.00% | 7.52% | 3.36% |
| 2025 | $3.44B | $-8.60M | 45.61% | 6.30% | -0.25% |